{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:51:32Z","timestamp":1776779492403,"version":"3.51.2"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T00:00:00Z","timestamp":1554508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan","award":["(C) (KAKENHI 18K07115)"],"award-info":[{"award-number":["(C) (KAKENHI 18K07115)"]}]},{"name":"Research Grant for Neuroimmunological Diseases from the Ministry of Health, Labour and Welfare of Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00415-019-09308-x","type":"journal-article","created":{"date-parts":[[2019,4,7]],"date-time":"2019-04-07T01:34:27Z","timestamp":1554600867000},"page":"1655-1662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Antecedent infections in Fisher syndrome: sources of variation in clinical characteristics"],"prefix":"10.1007","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1356-955X","authenticated-orcid":false,"given":"Michiaki","family":"Koga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Fukusako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Ikuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,6]]},"reference":[{"key":"9308_CR1","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung HP (2012) Guillain\u2013Barr\u00e9 syndrome. N Engl J Med 366:2294\u20132304","journal-title":"N Engl J Med"},{"key":"9308_CR2","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","volume":"51","author":"BC Jacobs","year":"1998","unstructured":"Jacobs BC, Rothbarth PH, van der Mech\u00e9 FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA (1998) The spectrum of antecedent infections in Guillain\u2013Barr\u00e9 syndrome: a case\u2013control study. Neurology 51:1110\u20131115","journal-title":"Neurology"},{"key":"9308_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/cen3.12457","volume":"9","author":"M Koga","year":"2018","unstructured":"Koga M (2018) Experimental approach in research of Guillain\u2013Barr\u00e9 syndrome: a range of pathogeneses mediated by molecular mimicry. Clin Exp Neuroimmunol 9:93\u2013100","journal-title":"Clin Exp Neuroimmunol"},{"key":"9308_CR4","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1212\/WNL.56.6.758","volume":"56","author":"RD Hadden","year":"2001","unstructured":"Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV, Plasma Exchange\/Sandoglobulin Guillain\u2013Barr\u00e9 Syndrome Trial Group (2001) Preceding infections, immune factors, and outcome in Guillain\u2013Barr\u00e9 syndrome. Neurology 56:758\u2013765","journal-title":"Neurology"},{"key":"#cr-split#-9308_CR5.1","doi-asserted-by":"crossref","unstructured":"Chiba A (2016) Miller Fisher syndrome. In Willison HJ, Goodfellow JA","DOI":"10.1007\/978-4-431-55594-0_11"},{"key":"#cr-split#-9308_CR5.2","unstructured":"(ed) GBS100: celebrating a century of progress in Guillain-Barr\u00e9 syndrome. Peripheral Nerve Society, La Jolla, pp 109-119.   https:\/\/core.ac.uk\/download\/pdf\/74362846.pdf#search=%27ISBN9780997510300%27    . Accessed 1 Apr 2019"},{"key":"9308_CR6","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1212\/01.WNL.0000160399.08456.7C","volume":"64","author":"M Koga","year":"2005","unstructured":"Koga M, Gilbert M, Li J, Koike S, Takahashi M, Furukawa K, Hirata K, Yuki N (2005) Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 64:1605\u20131611","journal-title":"Neurology"},{"key":"9308_CR7","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s00415-011-6360-y","volume":"259","author":"M Koga","year":"2012","unstructured":"Koga M, Gilbert M, Takahashi M, Li J, Hirata K, Kanda T, Yuki N (2012) GQ1b-seronegative Fisher syndrome: clinical features and new serological markers. J Neurol 259:1366\u20131374","journal-title":"J Neurol"},{"issue":"8093","key":"9308_CR8","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2(8093):750\u2013753","journal-title":"Lancet"},{"key":"9308_CR9","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1007\/s00415-015-7806-4","volume":"262","author":"M Koga","year":"2015","unstructured":"Koga M, Takahashi M, Yokoyama K, Kanda T (2015) Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain\u2013Barr\u00e9 syndrome and its variants. J Neurol 262:1954\u20131960","journal-title":"J Neurol"},{"key":"9308_CR10","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1212\/01.WNL.0000061615.77865.83","volume":"60","author":"M Koga","year":"2003","unstructured":"Koga M, Yuki N, Hirata K, Morimatsu M, Mori M, Kuwabara S (2003) Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain\u2013Barr\u00e9 syndrome. Neurology 60:1514\u20131518","journal-title":"Neurology"},{"key":"9308_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/jnnp.70.1.50","volume":"70","author":"M Odaka","year":"2001","unstructured":"Odaka M, Yuki N, Hirata K (2001) Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 70:50\u201355","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9308_CR12","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1136\/jnnp.2006.087940","volume":"77","author":"K Kaida","year":"2006","unstructured":"Kaida K, Kanzaki M, Morita D, Kamakura K, Motoyoshi K, Hirakawa M, Kusunoki S (2006) Anti-ganglioside complex antibodies in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 77:1043\u20131146","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9308_CR13","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1136\/jnnp.2007.142950","volume":"79","author":"M Kanzaki","year":"2008","unstructured":"Kanzaki M, Kaida K, Ueda M, Morita D, Hirakawa M, Motoyoshi K, Kamakura K, Kusunoki S (2008) Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain\u2013Barre syndromes. J Neurol Neurosurg Psychiatry 79:1148\u20131152","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9308_CR14","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1212\/WNL.47.3.668","volume":"47","author":"LH Visser","year":"1996","unstructured":"Visser LH, van der Mech\u00e9 FG, Meulstee J, Rothbarth PP, Jacobs BC, Schmitz PI, van Doorn PA (1996) Cytomegalovirus infection and Guillain\u2013Barr\u00e9 syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain\u2013Barr\u00e9 Study Group. Neurology 47:668\u2013673","journal-title":"Neurology"},{"key":"9308_CR15","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/cid\/cir074","volume":"52","author":"D Orlikowski","year":"2011","unstructured":"Orlikowski D, Porcher R, Sivadon-Tardy V, Quincampoix JC, Rapha\u00ebl JC, Durand MC, Sharshar T, Roussi J, Caudie C, Annane D, Rozenberg F, Leruez-Ville M, Gaillard JL, Gault E (2011) Guillain\u2013Barr\u00e9 syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis 52:837\u2013844","journal-title":"Clin Infect Dis"},{"key":"9308_CR16","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1007\/s00415-011-6042-9","volume":"258","author":"C Caudie","year":"2011","unstructured":"Caudie C, Quittard Pinon A, Taravel D, Sivadon-Tardy V, Orlikowski D, Rozenberg F, Sharshar T, Rapha\u00ebl JC, Gaillard JL (2011) Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain\u2013Barr\u00e9 syndrome patients. J Neurol 258:1958\u20131964","journal-title":"J Neurol"},{"key":"9308_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0165-5728(96)00059-8","volume":"68","author":"S Irie","year":"1996","unstructured":"Irie S, Saito T, Nakamura K, Kanazawa N, Ogino M, Nukazawa T, Ito H, Tamai Y, Kowa H (1996) Association of anti-GM2 antibodies in Guillain\u2013Barr\u00e9 syndrome with acute cytomegalovirus infection. J Neuroimmunol 68:19\u201326","journal-title":"J Neuroimmunol"},{"key":"9308_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/jnnp.62.6.641","volume":"62","author":"BC Jacobs","year":"1997","unstructured":"Jacobs BC, van Doorn PA, Groeneveld JH, Tio-Gillen AP, van der Mech\u00e9 FG (1997) Cytomegalovirus infections and anti-GM2 antibodies in Guillain\u2013Barr\u00e9 syndrome. J Neurol Neurosurg Psychiatry 62:641\u2013643","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9308_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1212\/WNL.0000000000000566","volume":"83","author":"S Sawai","year":"2014","unstructured":"Sawai S, Satoh M, Mori M, Misawa S, Sogawa K, Kazami T, Ishibashi M, Beppu M, Shibuya K, Ishige T, Sekiguchi Y, Noda K, Sato K, Matsushita K, Kodera Y, Nomura F, Kuwabara S (2014) Moesin is a possible target molecule for cytomegalovirus-related Guillain\u2013Barr\u00e9 syndrome. Neurology 83:113\u2013117","journal-title":"Neurology"},{"key":"9308_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0022-510X(97)00174-3","volume":"154","author":"N Yuki","year":"1998","unstructured":"Yuki N, Tagawa Y (1998) Acute cytomegalovirus infection and IgM anti-GM2 antibody. J Neurol Sci 154:14\u201317","journal-title":"J Neurol Sci"},{"key":"9308_CR21","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1212\/WNL.0000000000001090","volume":"83","author":"K Miyaji","year":"2014","unstructured":"Miyaji K, Devaux J, Yuki N (2014) Moesin is a possible target molecule for cytomegalovirus-related Guillain\u2013Barr\u00e9 syndrome. Neurology 83:2314","journal-title":"Neurology"},{"key":"9308_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jneuroim.2007.11.017","volume":"194","author":"BC Jacobs","year":"2008","unstructured":"Jacobs BC, Koga M, van Rijs W, Geleijns K, van Doorn PA, Willison HJ, Yuki N (2008) Subclass IgG to motor gangliosides related to infection and clinical course in Guillain\u2013Barr\u00e9 syndrome. J Neuroimmunol 194:181\u2013190","journal-title":"J Neuroimmunol"},{"key":"9308_CR23","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/cid\/cit512","volume":"57","author":"CH Geurtsvankessel","year":"2013","unstructured":"Geurtsvankessel CH, Islam Z, Mohammad QD, Jacobs BC, Endtz HP, Osterhaus AD (2013) Hepatitis E and Guillain-Barre syndrome. Clin Infect Dis 57:1369\u20131370","journal-title":"Clin Infect Dis"},{"key":"9308_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1212\/WNL.0000000000000111","volume":"82","author":"B Berg van den","year":"2014","unstructured":"van den Berg B, van der Eijk AA, Pas SD, Hunter JG, Madden RG, Tio-Gillen AP, Dalton HR, Jacobs BC (2014) Guillain\u2013Barr\u00e9 syndrome associated with preceding hepatitis E virus infection. Neurology 82:491\u2013497","journal-title":"Neurology"},{"key":"9308_CR25","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s10072-016-2644-4","volume":"37","author":"J Fukae","year":"2016","unstructured":"Fukae J, Tsugawa J, Ouma S, Umezu T, Kusunoki S, Tsuboi Y (2016) Guillain\u2013Barr\u00e9 and Miller Fisher syndromes in patients with anti-hepatitis E virus antibody: a hospital-based survey in Japan. Neurol Sci 37:1849\u20131851.z","journal-title":"Neurol Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09308-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09308-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09308-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T23:16:57Z","timestamp":1586042217000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09308-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,6]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["9308"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09308-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,6]]},"assertion":[{"value":"7 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors reports any disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the Institutional Review Board of Yamaguchi University Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}